Skip to main content

Development of a sensitivity-advanced electrophoretic point-of-care biosensor system.

FJC2020-043927-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Juan de la Cierva Formación
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Simultaneous quantification of six major allergens in commercial foods for children using a Multiplex Array on a Digital Versatile Disc

  • Sena-Torralba, Amadeo
  • Smits, Nathalie G.E.
  • Blázquez, David
  • Albero-Pérez, Clara
  • Pallás-Tamarit, Yeray|||0000-0002-1167-5631
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
[EN] The hypothesis of this study is centered around the logic that an enhanced analysis of potential allergens during the food production can lead to increased accuracy and reliability of food labeling. The development of a cost-effective and straightforward optoelectrical microanalytical system for the simultaneous quantification of the six most common food allergens (peanut, hazelnut, almond, milk, wheat, and soybean) is presented. The system uses a regular versatile disc (DVD) functionalized with highly selective antibodies in a microarray format and a DVD drive as the optical detector. The multiplexed assay reliably (RSD < 20 %) determines the level of the allergenic proteins ranging from 0.1 to 143.4 ng mL-1. The analysis of food consumables (biscuits, seafood substitutes, and probiotic foods) revealed a 100 % accuracy in identifying the allergens ingredients declared on the label. The method offers potential for application as a high throughput biosensing tool for screening multiple allergens in commercial foods., The research team acknowledges financial support from Paymsa. S. M. awards grant PID2019-110713RB-I00 funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe". The research was also supported by the Generalitat Valenciana (PROMETEO/2020/094, Proyecto "88/2021"). A. S. acknowledges MINECO for the Juan de la Cierva Formacion fellowship (FJC2020-043927-I). The researchers also gratefully thank Robbie Jennings for carefully revising the English throughout the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Lateral Flow Microimmunoassay (LFIA) for the Reliable Quantification of Allergen Traces in Food Consumables

  • Sena-Torralba, Amadeo
  • Gabaldón-Atienza, Javier
  • Casino, Patricia
  • Cubells-Gómez, Aitor|||0000-0001-6844-3439
  • Maquieira, Angel|||0000-0003-4641-4957
  • Morais, Sergi|||0000-0002-3722-2358
[EN] Quality assurance and food safety are of great concern within the food industry because of unknown quantities of allergens often present in food. Therefore, there is an ongoing need to develop rapid, sensitive, and easy to use methods that serve as an alternative to mass spectrometry and enzyme-linked immunosorbent assay (ELISA) for monitoring food safety. Lateral flow immunoassay is one of the most used point-of-need devices for clinical, environmental, and food safety applications. Compared to traditional methods, it appears to be a simple and fast alternative for detecting food allergens. However, its reliability is frequently questioned due to the lack of quantitative information. In this study, a lateral flow microimmunoassay (LFuIA) is presented that integrates up to 36 spots in microarray format in a single strip, providing semi-quantitative information about the level of allergens, positive and negative controls, internal calibration, and hook effect. The LF IA has been evaluated for the on-site simultaneous and reliable quantification of almond and peanut allergens as a proof of concept, demonstrating high sensitivity (185 and 229 ug/kg, respectively), selectivity (77%), and accuracy (RSD 5¿25%) when analyzing commercial allergen-suspicious food consumables., S.M. awards grant PID2019-110713RB-I00 was funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe. P.C. awards grant PID2019-110630 GB-I00 was funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe. The Generalitat Valenciana also supported the research (PROMETEO/2020/094, Proyecto 88/2021). A.S. acknowledges MINECO for the Juan de la Cierva Formación fellowship (FJC2020-043927-I).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Toward next generation lateral flow assays: Integration of nanomaterials

  • Sena-Torralba, Amadeo
  • Álvarez-Diduk, Ruslan
  • Parolo, Claudio
  • Piper, Andrew
  • Merkoçi, Arben
Lateral flow assays (LFAs) are currently the most used point-of-care sensors for both diagnostic (e.g., pregnancy test, COVID-19 monitoring) and environmental (e.g., pesticides and bacterial monitoring) applications. Although the core of LFA technology was developed several decades ago, in recent years the integration of novel nanomaterials as signal transducers or receptor immobilization platforms has brought improved analytical capabilities. In this Review, we present how nanomaterial-based LFAs can address the inherent challenges of point-of-care (PoC) diagnostics such as sensitivity enhancement, lowering of detection limits, multiplexing, and quantification of analytes in complex samples. Specifically, we highlight the strategies that can synergistically solve the limitations of current LFAs and that have proven commercial feasibility. Finally, we discuss the barriers toward commercialization and the next generation of LFAs., We acknowledge financial support to the project AC21_2/00044 (GLEBIOASSAY), funded by Instituto de Salud Carlos III (ISCIII) and cofunded by the European Union, MICROBPREDICT project (European Union Horizon 2020 research and innovation program under grant agreement 825694), and Graphene Flagship Core 3 (European Union Horizon 2020 research and innovation program under grant agreement 881603). ICN2 is funded by CERCA programme, Generalitat de Catalunya. Grant SEV-2017-0706 is funded by MCIN/AEI/10.13039/501100011033. The authors also acknowledge the Project PID2021-124795NB-I00 funded by MCIN/AEI/10.13039/501100011033/and FEDER Una manera de hacer Europa and the project PAPYRUS: Grant PLEC2021-007972 funded by MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”. The authors acknowledge Consejo Superior de Investigaciones Científicas (CSIC) for the project “COVID19-122” granted in the call “Nuevas ayudas extraordinarias a proyectos de investigación en el marco de las medidas urgentes extraordinarias para hacerfrente al impacto económico y social del COVID-19” (Ayudas CSIC-COVID-19). A.S.-T. acknowledges MINECO for the Juan de la Cierva Formación fellowship (FJC2020-043927-I). C.P. acknowledges the Marie Skłodowska-Curie Actions Individual Fellowship; this project received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 795635. C.P. (ISGlobal) also acknowledges support from the Spanish Ministry of Science and Innovation** and State Research Agency through the “Centro de Excelencia Severo Ochoa 2019−2023” Program (CEX2018-000806-S)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Toward Next Generation Lateral Flow Assays, Integration of Nanomaterials

  • Sena-Torralba, Amadeo|||0000-0003-1340-1383
  • Álvarez Diduk, Ruslan|||0000-0002-9876-1574
  • Parolo, Claudio|||0000-0001-9481-4408
  • Piper, Andrew|||0000-0002-1208-8009
  • Merkoçi, Arben|||0000-0003-2486-8085
Lateral flow assays (LFAs) are currently the most used point-of-care sensors for both diagnostic (e.g., pregnancy test, COVID-19 monitoring) and environmental (e.g., pesticides and bacterial monitoring) applications. Although the core of LFA technology was developed several decades ago, in recent years the integration of novel nanomaterials as signal transducers or receptor immobilization platforms has brought improved analytical capabilities. In this Review, we present how nanomaterial-based LFAs can address the inherent challenges of point-of-care (PoC) diagnostics such as sensitivity enhancement, lowering of detection limits, multiplexing, and quantification of analytes in complex samples. Specifically, we highlight the strategies that can synergistically solve the limitations of current LFAs and that have proven commercial feasibility. Finally, we discuss the barriers toward commercialization and the next generation of LFAs.